Chunghwa

1762.TW

Tags: TW Healthcare Biotechnology

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Price (1762.TW)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

78,092,000

(0.5197)%

Market Cap of Chunghwa (1762.TW)

Market cap:

As of , 1762.TW has a market cap of . This makes 1762.TW the 777th most valuable company in the TW by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Revenue and Profitability

Year	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Revenue	1,126,848,000	1,197,243,000	1,200,576,000	1,329,584,000	1,043,480,000	946,704,000	1,162,211,000	1,198,670,000	1,168,248,000	1,019,452,000	1,156,642,000	1,543,589,000	1,934,702,000	2,117,144,000	2,086,440,999
Net Income	245,105,000	187,004,000	170,994,000	175,564,000	96,825,000	14,592,000	308,356,000	60,283,000	85,766,000	234,251,000	117,003,000	531,873,000	400,778,000	465,865,000	264,909,000
FCF USD	425,522,000	224,116,000	77,723,000	-494,487,000	35,196,000	-123,508,000	-49,573,000	146,457,000	-646,461,000	140,937,000	153,333,000	-54,748,000	-186,274,000	357,595,000	-517,825,000
OCF USD	462,069,000	275,614,000	144,843,000	268,465,000	145,240,000	23,081,000	79,705,000	261,313,000	159,339,000	234,664,000	268,128,000	138,235,000	219,179,000	733,779,000	-66,274,000

Financial Health - DEBT

Year	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
YTPD	0.00	0.08	0.00	2.93	4.75	17.15	0.39	1.07	5.18	2.36	4.19	0.00	1.21	0.86	2.66
D/E	0.42	0.04	0.11	0.47	0.55	0.73	0.31	0.29	0.65	0.40	0.44	0.00	0.26	0.19	0.36
CA/CL	1.11	1.82	1.73	1.18	1.26	1.78	1.36	1.19	1.27	1.44	1.19	2.50	2.14	2.36	2.15
TA/TL	2.07	3.45	3.40	2.25	2.29	2.02	2.85	2.86	2.12	2.60	2.42	4.85	2.95	3.33	2.84
Total Debt	489,775,000	70,000,000	179,982,000	779,964,000	910,231,000	1,150,688,000	560,226,000	510,243,000	1,190,063,000	798,588,000	896,298,000	4,286,000	753,553,000	604,545,000	1,209,113,000

Management Performance

Year	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
ROIC	13.92%	9.25%	6.75%	7.10%	2.92%	0.30%	3.42%	2.51%	1.88%	1.00%	3.99%	19.49%	10.74%	11.33%	4.60%
ROE	21.05%	11.69%	10.70%	10.48%	5.86%	0.93%	16.80%	3.40%	4.71%	11.81%	5.81%	21.29%	13.85%	14.59%	7.91%
ROA	0.00%	10.51%	6.97%	5.82%	3.74%	1.18%	11.71%	3.42%	3.18%	7.46%	4.18%	20.66%	11.36%	12.78%	5.12%
NM %	21.75%	15.62%	14.24%	13.20%	9.28%	1.54%	26.53%	5.03%	7.34%	22.98%	10.12%	34.46%	20.72%	22.00%	12.70%
FCF / R%	0.00%	18.72%	6.47%	-37.19%	3.37%	-13.05%	-4.27%	12.22%	-55.34%	13.82%	13.26%	-3.55%	-9.63%	16.89%	-24.82%
FCF / NI%	172.71%	89.99%	46.96%	-281.66%	30.96%	-325.82%	-14.75%	157.33%	-590.18%	58.66%	106.67%	-8.42%	-37.43%	61.30%	-195.47%
Operating Margin (OM)	0.00	0.21	0.20	0.22	0.25	0.49	0.39	0.31	0.35	0.54	0.48	0.67	0.69	0.79	0.84

Per Share

Year	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
EPS	3.62	2.62	2.20	2.26	1.25	0.19	3.98	0.78	1.11	3.02	1.51	6.86	5.17	6.01	3.42
SPS	16.64	16.76	15.48	17.14	13.45	12.21	14.98	15.45	15.06	13.14	14.91	19.90	24.94	27.30	26.90
OCPS	6.83	3.86	1.87	3.46	1.87	0.30	1.03	3.37	2.05	3.03	3.46	1.78	2.83	9.46	-0.85
FCPS	6.29	3.14	1.00	-6.38	0.45	-1.59	-0.64	1.89	-8.33	1.82	1.98	-0.71	-2.40	4.61	-6.68
BVPS	17.64	23.56	21.62	21.60	22.06	20.83	24.03	22.84	23.48	25.58	25.98	32.22	37.32	41.17	43.20

Per Share - CAGR

Year	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
CAGR-EPS	3.62	2.62	2.20	2.26	1.25	0.19	3.98	0.78	1.11	3.02	1.51	6.86	5.17	6.01	3.42
CAGR-SPS	16.64	16.76	15.48	17.14	13.45	12.21	14.98	15.45	15.06	13.14	14.91	19.90	24.94	27.30	26.90
CAGR-OCPS	6.83	3.86	1.87	3.46	1.87	0.30	1.03	3.37	2.05	3.03	3.46	1.78	2.83	9.46	-0.85
CAGR-FCPS	6.29	3.14	1.00	-6.38	0.45	-1.59	-0.64	1.89	-8.33	1.82	1.98	-0.71	-2.40	4.61	-6.68
CAGR-BVPS	17.64	23.56	21.62	21.60	22.06	20.83	24.03	22.84	23.48	25.58	25.98	32.22	37.32	41.17	43.20

Revenue $2.09B

-1.45%

10Y

Net Income $264.91M

-43.14%

10Y

Operating Cash Flow $-66,274,000.00

-109.03%

10Y

Free Cash Flow $-517,825,000.00

-244.81%

10Y

YTPD $2.66

+209.79%

10Y

D/E $0.36

+90.61%

10Y

CA/CL $2.15

-8.86%

10Y

TA/TL $2.84

-14.70%

10Y

ROIC $4.60%

-59.37%

10Y

ROE $7.91%

-45.81%

10Y

ROA $5.12%

-59.92%

10Y

Net Margin $12.70%

-42.30%

10Y

FCF / R% $-24.82%

-246.94%

10Y

FCFNI % $-195.47%

-418.85%

10Y

Operating Margin $0.84

+5.84%

10Y

EPS $3.42

-43.14%

10Y

SPS $26.90

-1.45%

10Y

OCPS $-0.85

-109.03%

10Y

FCPS $-6.68

-244.81%

10Y

BVPS $43.20

+4.92%

10Y

Wordpress Tutorials

eCommerce Website Tutorials

Responsive Design

Chunghwa

Stock Price

Fetching Data...

Fetching Data...

Fetching Data...

78,092,000

Market Cap of Chunghwa (1762.TW)

Market cap:

Year

Beginning Of Year

End Of Year

YOY Change

Revenue of Chunghwa (1762.TW)

Revenue:

Year

Revenue

YOY Change

Net Income of Chunghwa (1762.TW)

Net Income:

Year

Net Income

YOY Change

Free Cash Flow of Chunghwa (1762.TW)

Free Cash Flow:

Year

FreeCash flow

YOY Change

Operating Cash Flow of Chunghwa (1762.TW)

Operating Cash Flow:

Year

Operating Cashflow

YOY Change

Return on Invested capital of Chunghwa (1762.TW)

Return on Invested capital: %

%

Year

Return on Invested Capital

YOY Change

Return on Equity of Chunghwa (1762.TW)

Return on Equity: %

%

Year

Return on Equity

YOY Change

Return on Assets of Chunghwa (1762.TW)

Return on Assets: %

%

Year

ROA

YOY Change

Total debt of Chunghwa (1762.TW)

Total debt:

Year

MarketCap

YOY Change

Marketing Budget of Chunghwa (1762.TW)

Marketing Budget:

Year

MarketCap

YOY Change

Employee of Chunghwa (1762.TW)

Employee:

Year

Employees Number

YOY Change

Payroll of Chunghwa (1762.TW)

Payroll:

Year

Payroll

YOY Change

Dividends of Chunghwa (1762.TW)

Dividends:

Year

Dividends

YOY Change

Executive Compensation of Chunghwa (1762.TW)

Executive Compensation: